UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

265 BCL11A gene status and prediction of survival in triple negative breast cancer (TNBC) treated with anthracycline-based adjuvantchemotherapy

European journal of cancer (1990), 2015-09, Vol.51, p.S48-S48

2015

Volltextzugriff (PDF)

P17.44 THE EFFECT OF A SURGERY RATIONALE ON LIFE EXPECTANCY WITHIN PRIMARY GLIOBLASTOMA MULTIFORME PATIENTS: RESECTION COMPARE TO SOLE BIOPSY. SIX AND HALF YEAR REGULAR FOLLOW-UP EXPERIENCES OF ONE ONCO-CENTREDATABASE OF INTRACRANIAL TUMOURS (DOIT) OF CZECH REPUBLIC

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii97-ii97

2014

Volltextzugriff (PDF)

582 ALK Rearrangement and EGFR Copy Number Gains/mutations in Czech Non-small Cell Lung Cancer Patients

European journal of cancer (1990), 2012-07, Vol.48, p.S139-S139

2012

Volltextzugriff (PDF)

P14.68 Life expectancy in biopsied GBM patients: a single-centre experience

Neuro-oncology (Charlottesville, Va.), 2019-09, Vol.21 (Supplement_3), p.iii83-iii83

2019

Volltextzugriff (PDF)

Copy number variation and clinical response to chemotherapy and bevacizumab in the Czech metastatic colorectal cancer patients

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2024, Vol.38 (4), p.277

2024

Volltextzugriff (PDF)

P01.038 Drug resistance and recurrence in glioblastoma: molecular cytogenetic analysis in paired primary and recurrent form

Neuro-oncology (Charlottesville, Va.), 2018-09, Vol.20 (suppl_3), p.iii237-iii237

2018

Volltextzugriff (PDF)

P01.098 Have we been still defeated with treatment of GBM IDH wild-type recurrency

Neuro-oncology (Charlottesville, Va.), 2018-09, Vol.20 (suppl_3), p.iii253-iii253

2018

Volltextzugriff (PDF)

P06.09 Genetic alterations in patients with resection of primary glioblastoma multiforme gr.IV

Neuro-oncology (Charlottesville, Va.), 2016-10, Vol.18 (suppl_4), p.iv29-iv29

2016

Volltextzugriff (PDF)

P08.70 Prognostic and predictive factors in primary Glioblastoma Multiforme WHO grade IV patients with resection: A single-institution study

Neuro-oncology (Charlottesville, Va.), 2016-10, Vol.18 (suppl_4), p.iv58-iv58

2016

Volltextzugriff (PDF)

P06.10 A retrospective single-center study of IDH mutations in gliomas

Neuro-oncology (Charlottesville, Va.), 2016-10, Vol.18 (suppl_4), p.iv29-iv30

2016

Volltextzugriff (PDF)

P17.44THE EFFECT OF A SURGERY RATIONALE ON LIFE EXPECTANCY WITHIN PRIMARY GLIOBLASTOMA MULTIFORME PATIENTS: RESECTION COMPARE TO SOLE BIOPSY. SIX AND HALF YEAR REGULAR FOLLOW-UP EXPERIENCES OF ONE ONCO-CENTREDATABASE OF INTRACRANIAL TUMOURS (DOIT) OF CZECH REPUBLIC

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (Suppl 2), p.ii97-ii97

2014

Volltextzugriff (PDF)

Evaluation of HER2 gene status by qPCR in breast cancer samples with nonconclusive FISH

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.612-612

2011

Volltextzugriff (PDF)

A Patient with Primary Intraventricular Gliosarcoma and Long-term Survival - a Case Report

Klinická onkologie, 2016, Vol.29 (6), p.454-459

2016

Volltextzugriff (PDF)

Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas

Klinická onkologie, 2017, Vol.30 (5), p.361-371

2017

Volltextzugriff (PDF)

Role of CCND1 and C-MYC oncogenes in metastatic breast cancer patients treated by herceptin

Breast cancer research : BCR, 2011-11, Vol.13 (Suppl 2), p.P9-P9, Article P9

2011

Volltextzugriff (PDF)

BCL2 is a predictive marker of adjuvant CMF regimen in triple-negative breast cancer patients

Breast cancer research : BCR, 2011-11, Vol.13 (Suppl 2), p.P8-P8, Article P8

2011

Volltextzugriff (PDF)

Abstract P2-09-30: Impact of PIK3CA, PTEN and RPS6 Status on Lapatinib Treatment Outcome in Advanced-Stage Breast Cancer Patients

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P2-P2-09-30

2010

Volltextzugriff (PDF)

Chromosome 17 polysomy and Her-2/neu status in metastatic breast cancer patients indicated to trastuzumab therapy

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.9584-9584

2005

Volltextzugriff (PDF)

Anthracycline based chemotherapy decreases amplification status of Her-2/neu and topoisomerase II alpha genes in locally advanced breast cancer

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9521-9521

2004

Volltextzugriff (PDF)

Anthracycline based chemotherapy decreases amplification status of Her-2/neu and topoisomerase II alpha genes in locally advanced breast cancer

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9521-9521

2004

Volltextzugriff (PDF)

What is the real importance of evaluating the expression of c-erbB-2 (HER-2/neu) in carcinoma of the breast and prostate? (A short review)

Ceskoslovenské patologie, 2002, Vol.38 Suppl 1, p.15

2002

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(21)

Sprache

Englisch
(20)
Tschechisch
(2)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

265 BCL11A gene status and prediction of survival in triple negative breast cancer (TNBC) treated with anthracycline-based adjuvantchemotherapy

P17.44 THE EFFECT OF A SURGERY RATIONALE ON LIFE EXPECTANCY WITHIN PRIMARY GLIOBLASTOMA MULTIFORME PATIENTS: RESECTION COMPARE TO SOLE BIOPSY. SIX AND HALF YEAR REGULAR FOLLOW-UP EXPERIENCES OF ONE ONCO-CENTREDATABASE OF INTRACRANIAL TUMOURS (DOIT) OF CZECH REPUBLIC

582 ALK Rearrangement and EGFR Copy Number Gains/mutations in Czech Non-small Cell Lung Cancer Patients

P14.68 Life expectancy in biopsied GBM patients: a single-centre experience

Copy number variation and clinical response to chemotherapy and bevacizumab in the Czech metastatic colorectal cancer patients

P01.038 Drug resistance and recurrence in glioblastoma: molecular cytogenetic analysis in paired primary and recurrent form

P01.098 Have we been still defeated with treatment of GBM IDH wild-type recurrency

P06.09 Genetic alterations in patients with resection of primary glioblastoma multiforme gr.IV

P08.70 Prognostic and predictive factors in primary Glioblastoma Multiforme WHO grade IV patients with resection: A single-institution study

P06.10 A retrospective single-center study of IDH mutations in gliomas

P17.44THE EFFECT OF A SURGERY RATIONALE ON LIFE EXPECTANCY WITHIN PRIMARY GLIOBLASTOMA MULTIFORME PATIENTS: RESECTION COMPARE TO SOLE BIOPSY. SIX AND HALF YEAR REGULAR FOLLOW-UP EXPERIENCES OF ONE ONCO-CENTREDATABASE OF INTRACRANIAL TUMOURS (DOIT) OF CZECH REPUBLIC

Evaluation of HER2 gene status by qPCR in breast cancer samples with nonconclusive FISH

A Patient with Primary Intraventricular Gliosarcoma and Long-term Survival - a Case Report

Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas

Role of CCND1 and C-MYC oncogenes in metastatic breast cancer patients treated by herceptin

BCL2 is a predictive marker of adjuvant CMF regimen in triple-negative breast cancer patients

Abstract P2-09-30: Impact of PIK3CA, PTEN and RPS6 Status on Lapatinib Treatment Outcome in Advanced-Stage Breast Cancer Patients

Chromosome 17 polysomy and Her-2/neu status in metastatic breast cancer patients indicated to trastuzumab therapy

Anthracycline based chemotherapy decreases amplification status of Her-2/neu and topoisomerase II alpha genes in locally advanced breast cancer

Anthracycline based chemotherapy decreases amplification status of Her-2/neu and topoisomerase II alpha genes in locally advanced breast cancer

What is the real importance of evaluating the expression of c-erbB-2 (HER-2/neu) in carcinoma of the breast and prostate? (A short review)

Aktive Filter

Suchergebnisse filtern